Zhipu leads rally in Chinese AI stocks, surging 30% as a wave of new releases hits market
The Shanghai STAR AI Industry Index climbed 1.7% before paring gains.
A year into Trump tariffs, Chinese factories and ports are buzzing with activity
A year after Trump’s tariffs spooked manufacturers and customers, Chinese factories and ports were humming unfethered ahead of the Lunar New Year holiday.
Meet the high-profile Emirati business leader lawmakers are linking to Epstein ‘torture’ email
U.S. officials have identified DP World’s Sultan Ahmed bin Sulayem as the recipient of a 2009 email from Jeffrey Epstein regarding a supposed “torture video.”
CNBC Daily Open: Better-than-expected U.S. jobs report and AI fears spook markets
U.S. stocks went down after the report came out Wednesday stateside, with the Dow snapping a three-day winning streak.
Japan stocks extend post-election rally with Nikkei 225 breaching 58,000 for the first time
Other markets in Asia also shrugged off strong U.S. payrolls data that has dampened expectations for Federal Reserve rate cuts and sent Wall Street lower overnight.
Dow slides 600 points, S&P 500 falls for a third day as AI disruption fears rattle markets: Live updates
Wall Street is coming off a weak session for the major averages as traders assessed what the latest jobs report means for the interest rate outlook.
Epstein files: AG Pam Bondi seemed to have Rep. Jayapal’s DOJ database search history at hearing
Attorney General Pam Bondi at a House Judiciary Committee hearing seemed to have a printout of Rep. Jayapal’s search history related to Epstein.
Trump orders Pentagon to buy power from coal plants
Trump declared coal essential to U.S. national and economic security last April.
Cisco’s stock drops 7% on mediocre forecast even as earnings and revenue top estimates
Cisco reported revenue growth in the quarter of close to 10%, topping analysts’ estimates.
Novo Nordisk faces a defining year in the obesity drug market. It’s off to a dramatic start
The Danish drugmaker kicked off 2026 with its explosive obesity pill launch, but recent challenges have centered around protecting its market share.
